Page last updated: 2024-11-01

norfloxacin and Gastric Ulcer

norfloxacin has been researched along with Gastric Ulcer in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugita, K1
Katouno, Y1
Uchida, H1
Kobayashi, Y1
Gupta, VK1
Dhar, A1
Srinivasan, S1
Rattan, A1
Sharma, MP1

Trials

1 trial available for norfloxacin and Gastric Ulcer

ArticleYear
Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug

1997

Other Studies

1 other study available for norfloxacin and Gastric Ulcer

ArticleYear
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromyc

2002